ChemicalBook >> CAS DataBase List >>SCO-267

SCO-267

CAS No.
1656261-09-4
Chemical Name:
SCO-267
Synonyms
SCO-267;4-Pyridinepropanoic acid, β-cyclopropyl-2-[[1-[2-[[(2,2-dimethylpropyl)(6-methyl-2-pyridinyl)amino]carbonyl]-5-methoxyphenyl]-4-piperidinyl]methoxy]-, (βS)-
CBNumber:
CB19702014
Molecular Formula:
C36H46N4O5
Molecular Weight:
614.79
MDL Number:
MFCD34474242
MOL File:
1656261-09-4.mol
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-05-27 23:51:45

SCO-267 Properties

Boiling point 792.7±60.0 °C(Predicted)
Density 1.201±0.06 g/cm3(Predicted)
pka 4.11±0.10(Predicted)
form Solid
color Off-white to light yellow

SAFETY

Risk and Safety Statements

Symbol(GHS)  Exclamation Mark (GHS07)
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319
Precautionary statements  P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

SCO-267 price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Biosynth BS179509 SCO-267 1656261-09-4 1mg $199.65 2026-06-04 Buy
Biosynth BS179509 SCO-267 1656261-09-4 2mg $332.76 2026-06-04 Buy
Biosynth BS179509 SCO-267 1656261-09-4 5mg $623.95 2026-06-04 Buy
Biosynth BS179509 SCO-267 1656261-09-4 10mg $1081.5 2026-06-04 Buy
Biosynth BS179509 SCO-267 1656261-09-4 25mg $2162.75 2026-06-04 Buy
Product number Packaging Price Buy
BS179509 1mg $199.65 Buy
BS179509 2mg $332.76 Buy
BS179509 5mg $623.95 Buy
BS179509 10mg $1081.5 Buy
BS179509 25mg $2162.75 Buy

SCO-267 Chemical Properties, Uses, Production

Description

SCO-267 is a novel GPR40 full agonist, improving liver parameters in a mouse model of nonalcoholic fatty liver disease without affecting glucose or body weight.

Uses

SCO-267 is an allosteric GPR40 full agonist. SCO-267 can be used for the research of chronic diseases including diabetes[1].

in vivo

SCO-267 (1 or 10 mg/kg; p.o.) improves insulin sensitivity and exerts sustained glucose-lowering effect[1].

Animal Model:N-STZ rats[1]
Dosage:1 or 10 mg/kg
Administration:P.o.;
Result:Improved insulin sensitivity and exerted sustained glucose-lowering effect.

References

[1] Koyama R, et al. Chronic Exposure to SCO-267, an Allosteric GPR40 Full Agonist, Is Effective in Improving Glycemic Control in Rats. Mol Pharmacol. 2021 Apr;99(4):286-293. DOI:10.1124/molpharm.120.000168

SCO-267 Preparation Products And Raw materials

Raw materials

Preparation Products

SCO-267 Suppliers

Global Suppliers ( 22)
Supplier Tel Email Country ProdList Advantage
Changsha Fuzhen Biotechnology Co.,LTD 15111215862 18229892877 3062105966@qq.com China 5550 58
ShangHai Biochempartner Co.,Ltd 177-54423994 17754423994 2853530910@QQ.com China 8000 62
Changzhou Chenhong Biotechnology Co., Ltd. +86-0519-85788828 +86-13775037613 sales@chemrenpharm.com China 4058 58
Hengyang Jiaxuan Biotechnology Co. LTD 18684598761 675042965@qq.com China 308 58
Birdo (Shanghai) Medical Technology Co., Ltd. 021-58099077-8041 18601625411 sales@birdotech.com China 9378 58
Suzhou youruike Chemical Pharmaceutical Technology Co., Ltd 15317229551 15151849396@163.com China 959 58
Taizhou Nanfeng Pharmaceutical Research Institute nanfengpharma@126.co 18616377689 nanfengpharma@126.com China 20008 58
SINO High Goal Chemical Technology Co., Ltd. 021-57646680 18306277365 guoxin@chembiobanksh.com China 2819 58
Bide Pharmatech Ltd. 400-1647117 13681763483 product02@bidepharm.com China 59929 58
Xi'an Kaixin Biotechnology Co., Ltd 029-68881181 13619217766 3495811982@qq.com China 2816 58

SCO-267 Spectrum

SCO-267 4-Pyridinepropanoic acid, β-cyclopropyl-2-[[1-[2-[[(2,2-dimethylpropyl)(6-methyl-2-pyridinyl)amino]carbonyl]-5-methoxyphenyl]-4-piperidinyl]methoxy]-, (βS)- 1656261-09-4